
Reset all filters
01 1ALKERAN
02 1AMIDATE
03 1ARGATROBAN
04 1ATIVAN
05 1DEFINITY
06 1DEFINITY RT
07 3DIAZEPAM
08 1DIGOXIN
09 1DOCETAXEL
10 5ETOMIDATE
11 4HYDRALAZINE HYDROCHLORIDE
12 1LANOXIN
13 1LANOXIN PEDIATRIC
14 3LORAZEPAM
15 1M.V.I. ADULT
16 2M.V.I.-12 ADULT
17 2MELPHALAN HYDROCHLORIDE
18 1NITROGLYCERIN
19 3NITROGLYCERIN IN DEXTROSE 5%
20 1PENTOBARBITAL SODIUM
21 4PHENYTOIN SODIUM
22 2SULFAMETHOXAZOLE AND TRIMETHOPRIM
Reset all filters
01 28809
02 29330
03 118140
04 118227
05 120124
06 120207
07 221064
08 121625
09 140136
10 140388
11 140573
12 140730
13 171583
14 171846
15 171847
16 171848
17 172034
18 172079
19 173303
20 174243
21 174282
22 175025
23 178289
24 178867
25 183391
26 184307
27 189521
28 189744
29 190270
30 191297
31 1202356
32 1203049
33 1204618
34 1204680
35 1206607
36 1206677
37 1209058
38 1210947
Reset all filters
01 39No
02 2Yes
Drug : PHENYTOIN SODIUM
Dosage Form : INJECTABLE; INJECTION
Application Number : 40573
Country : US
Patented : No
Drug : ETOMIDATE
Dosage Form : INJECTABLE; INJECTION
Application Number : 204618
Country : US
Patented : No
Drug : LANOXIN PEDIATRIC
Dosage Form : INJECTABLE; INJECTION
Application Number : 9330
Country : US
Patented : No
Drug : LANOXIN
Dosage Form : INJECTABLE; INJECTION
Application Number : 9330
Country : US
Patented : No
Drug : HYDRALAZINE HYDROCHLORIDE
Dosage Form : INJECTABLE; INJECTION
Application Number : 40388
Country : US
Patented : No
Drug : DEFINITY
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 21064
Country : US
Patented : Yes
Drug : ETOMIDATE
Dosage Form : INJECTABLE; INJECTION
Application Number : 78289
Country : US
Patented : No
Drug : LORAZEPAM
Dosage Form : INJECTABLE; INJECTION
Application Number : 75025
Country : US
Patented : No
Drug : HYDRALAZINE HYDROCHLORIDE
Dosage Form : INJECTABLE; INJECTION
Application Number : 40730
Country : US
Patented : No
Drug : DIAZEPAM
Dosage Form : INJECTABLE; INJECTION
Application Number : 20124
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF